Efficacy and Safety of a Transdermal Carbon Dioxide-Releasing Gel for the Treatment of Genitourinary Syndrome in Vulvar Cancer Survivors: A Prospective Pilot Study
Introduction: Genitourinary syndrome of menopause (GSM) is a major sequela in women with a history of vulvar cancer, exacerbated by surgical and radiotherapy treatments that compromise the anatomy and function of the lower genital tract. Hormonal therapeutic options are often limited in this population due to oncologic risks (1,2,7,8), emphasizing the need for safe and effective alternatives. In this context, transdermal carbon dioxide (CO₂)- releasing gels have demonstrated beneficial effects on microcirculation, tissue oxygenation, and cellular regeneration (23–29), offering an innovative non-hormonal strategy for managing vulvovaginal symptoms in cancer survivors. Objective: To evaluate the progression of vulvoperineal symptoms in patients with a history of vulvar cancer undergoing regenerative therapy. Materials and Methods: Five patients diagnosed with GSM were included. Regenerative treatment was applied, and 15 symptoms were evaluated at baseline, 6 weeks, and 3 months. Results: The mean total symptom burden decreased from 14.4 at baseline to 10.0 at 6 weeks, and to 0.8 at 3 months (94.4% reduction). Although paired comparisons did not reach statistical significance (p=0.0625), effect size measures (ARR and RRR) indicated clinically meaningful improvement in most symptoms. Conclusion: The regenerative protocol produced marked and sustained clinical improvement in GSM symptoms in patients with a history of vulvar cancer. Studies with larger sample sizes are warranted to confirm statistical significance. Keywords: Genitourinary syndrome, carbon dioxide-releasing transdermal gel, regenerative therapies, vulvar cancer survivors.
Authors
- Gustavo H. Leibaschoff (ORCID: https://orcid.org/0009-0005-3893-0849)
- Javier Enrique Serrano Ramos
- Marta Serrano Ramos
Institutions
- Universidad del Centro del Bajío (MX)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24419251
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00